To our knowledge, this is the first report of a patient carrying the MEN 2A-harboring germline RET-p.C634Y mutation worldwide, and the first systematic review of the evidence for ECS caused by MEN 2-related MTC and/or PHEO. This evidence concerns the gene RET and multiple endocrine neoplasia type 2A.